• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer reiterated coverage on ESSA Pharma with a new price target

    8/17/21 7:19:42 AM ET
    $EPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $EPIX alert in real time by email
    Oppenheimer reiterated coverage of ESSA Pharma with a rating of Outperform and set a new price target of $22.00 from $36.00 previously
    Get the next $EPIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EPIX

    DatePrice TargetRatingAnalyst
    11/4/2024Buy → Hold
    Jefferies
    11/4/2024Outperform → Perform
    Oppenheimer
    11/4/2024$15.00 → $2.00Overweight → Neutral
    Piper Sandler
    6/26/2023$17.00Outperform
    Oppenheimer
    8/17/2021$36.00 → $22.00Outperform
    Oppenheimer
    More analyst ratings

    $EPIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Parkinson David Ross bought $21,213 worth of shares (9,223 units at $2.30), increasing direct ownership by 16% to 65,675 units (SEC Form 4)

      4 - ESSA Pharma Inc. (0001633932) (Issuer)

      12/18/23 9:57:03 PM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Berger Franklin M bought $133,274 worth of shares (23,259 units at $5.73), increasing direct ownership by 3% to 784,404 units (SEC Form 4)

      4 - ESSA Pharma Inc. (0001633932) (Issuer)

      11/22/23 6:22:47 PM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Berger Franklin M bought $419,661 worth of shares (76,471 units at $5.49), increasing direct ownership by 11% to 760,875 units (SEC Form 4)

      4 - ESSA Pharma Inc. (0001633932) (Issuer)

      11/16/23 5:45:43 PM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $EPIX
    SEC Filings

    See more
    • ESSA Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - ESSA Pharma Inc. (0001633932) (Filer)

      5/8/25 7:04:05 AM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by ESSA Pharma Inc.

      10-Q - ESSA Pharma Inc. (0001633932) (Filer)

      5/8/25 7:00:30 AM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SCHEDULE 13D filed by ESSA Pharma Inc.

      SCHEDULE 13D - ESSA Pharma Inc. (0001633932) (Subject)

      4/24/25 8:56:37 AM ET
      $EPIX
      Biotechnology: Pharmaceutical Preparations
      Health Care